BackgroundMortality prediction is critical on long-term kidney replacement therapy (KRT), both for individual treatment decisions and resource planning. Many mortality prediction models already exist, but as a major shortcoming most of them have only been validated internally. This leaves reliability and usefulness of these models in other KRT populations, especially foreign, unknown. Previously two models were constructed for one- and two-year mortality prediction of Finnish patients starting long-term dialysis. These models are here internationally validated in KRT populations of the Dutch NECOSAD Study and the UK Renal Registry (UKRR). MethodsWe validated the models externally on 2051 NECOSAD patients and on two UKRR patient cohorts (532...
Background: There is no single model available to predict the long term survival for patients starti...
Background. Conservative care (CC) may be a valid alternative to dialysis for certain older patients...
BACKGROUND: There is no single model available to predict the long term survival for patients starti...
BackgroundMortality prediction is critical on long-term kidney replacement therapy (KRT), both for i...
Background. Mortality prediction is critical on long-term kidney replacement therapy (KRT), both for...
Mortality risk of patients with end-stage renal disease (ESRD) is highly elevated. Methods to estima...
Objective: In medicine, many more prediction models have been developed than are implemented or used...
An easy-to-use prediction model for long-term renal patient survival based on only four predictors [...
BACKGROUND: Risk prediction models can be used to inform patients undergoing renal replacement thera...
Background Various prediction models have been developed to predict the risk of kidney failure in pa...
Background Various prediction models have been developed to predict the risk of kidney failure in pa...
[[abstract]]Background Despite the continual improvements in dialysis treatments, mortality in end-s...
INTRODUCTION: Several factors affect the survival of End Stage Kidney Disease (ESKD) patients on dia...
BACKGROUND: While some prediction models have been developed for diabetic populations, prediction ru...
While some prediction models have been developed for diabetic populations, prediction rules for mort...
Background: There is no single model available to predict the long term survival for patients starti...
Background. Conservative care (CC) may be a valid alternative to dialysis for certain older patients...
BACKGROUND: There is no single model available to predict the long term survival for patients starti...
BackgroundMortality prediction is critical on long-term kidney replacement therapy (KRT), both for i...
Background. Mortality prediction is critical on long-term kidney replacement therapy (KRT), both for...
Mortality risk of patients with end-stage renal disease (ESRD) is highly elevated. Methods to estima...
Objective: In medicine, many more prediction models have been developed than are implemented or used...
An easy-to-use prediction model for long-term renal patient survival based on only four predictors [...
BACKGROUND: Risk prediction models can be used to inform patients undergoing renal replacement thera...
Background Various prediction models have been developed to predict the risk of kidney failure in pa...
Background Various prediction models have been developed to predict the risk of kidney failure in pa...
[[abstract]]Background Despite the continual improvements in dialysis treatments, mortality in end-s...
INTRODUCTION: Several factors affect the survival of End Stage Kidney Disease (ESKD) patients on dia...
BACKGROUND: While some prediction models have been developed for diabetic populations, prediction ru...
While some prediction models have been developed for diabetic populations, prediction rules for mort...
Background: There is no single model available to predict the long term survival for patients starti...
Background. Conservative care (CC) may be a valid alternative to dialysis for certain older patients...
BACKGROUND: There is no single model available to predict the long term survival for patients starti...